Skip to main content
. 2022 Mar 5;3:117–125. doi: 10.1016/j.ijregi.2022.02.007

Figure 3.

Figure 3

Mapping of the seroprevalence data obtained by ELISA (panels A, B, and C) and COVID-19 attack rate cases at the time of the household sero-survey (panel D).